busulfan has been researched along with Hand-Foot Syndrome in 1 studies
Hand-Foot Syndrome: Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kume, T | 1 |
| Shimizu, R | 1 |
| Akiyama, K | 1 |
| Tsuchiya, T | 1 |
| Shino, M | 1 |
| Ikeda, T | 1 |
| Iwai, S | 1 |
1 other study available for busulfan and Hand-Foot Syndrome
| Article | Year |
|---|---|
Hand-foot syndrome and risk factors for occurrence in hematopoietic stem cell transplantation recipients.
Topics: Busulfan; Female; Graft vs Host Disease; Hand-Foot Syndrome; Hematopoietic Stem Cell Transplantation | 2022 |